Rubicon Research Private Limited recalls AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ,…
- Recall date
- August 24, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0659-2024
- FDA classification
- Class III
- Brand / firm
- Rubicon Research Private Limited
- Sold / distributed
- Nationwide in the US
Why it was recalled
Discoloration
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
Get recall alerts
Free email alert whenever Rubicon Research Private Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Rubicon Research Private Limited